Role of soluble ST2 in short-term prediction of acute heart failure in acute ST-elevation myocardial infarction

Aim. To investigate the relationship of soluble ST2 (sST2) to acute heart failure (AHF) and compare the predictive value of sST2 and brain natriuretic peptide in patients with ST-elevation myocardial infarction (STEMI).Material and methods. In 136 STEMI patients, the serum sST2 concentration was det...

Full description

Bibliographic Details
Main Authors: O. S. Donirova, K. V. Protasov, B. A. Donirov, E. V. Batunova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2021-05-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/4308
_version_ 1797856662621519872
author O. S. Donirova
K. V. Protasov
B. A. Donirov
E. V. Batunova
author_facet O. S. Donirova
K. V. Protasov
B. A. Donirov
E. V. Batunova
author_sort O. S. Donirova
collection DOAJ
description Aim. To investigate the relationship of soluble ST2 (sST2) to acute heart failure (AHF) and compare the predictive value of sST2 and brain natriuretic peptide in patients with ST-elevation myocardial infarction (STEMI).Material and methods. In 136 STEMI patients, the serum sST2 concentration was determined during the first 24 hours of hospitalization. We assessed levels of sST2, N-terminal pro-brain natriuretic peptide (NT-proBNP), incidence of Killip class II-IV AHF during hospitalization, myocardial necrosis biomarkers, parameters of complete blood count and biochemical blood tests, the incidence of cardiovascular diseases and risk factors. The predictive value of sST2 for AHF development was assessed using logistic regression. ROC analysis was performed. The areas under the ROC curve were compared for sST2 and NT-proBNP. The cut-off sST2 value was determined for predicting AHF.Results. The mean sST2 level was 43,4 (33,6-73,9) ng/ml. During the followup period, AHF was diagnosed in 54 people (39,7%). The prevalence of AHF in the 1st, 2nd and 3rd tertiles of sST2 was 15,6%, 33,3% and 69,7%, respectively. The NT-proBNP levels were 319 (128-1072) pg/ml, 430 (147-1140) pg/ml and 1317 (533-2386) pg/ml. The predictive value of 3rd sST2 tertile was retained adjusted for age, sex, NT-proBNP, troponin T, creatine phosphokinase-MB, high-sensitivity C-reactive protein, hemoglobin, blood glucose, left ventricular ejection fraction. The areas under the ROC curves for sST2 and NT-proBNP were comparable (0,828 and 0,733, respectively; p=0,056). The cut-off sST2 value was 64 ng/ml, above which the odds ratio of AHF was 11,1 (95% confidence interval, 4,7-26,1.Conclusion. An increase in blood sST2 is associated with an increase in AHF (Killip II-IV) prevalence in hospitalized patients with acute STEMI. Soluble ST2 has an independent predictive value for AHF in STEMI, comparable in strength and predictive model quality to NT-proBNP. The cut-off sST2 value for AHF (>64 ng/ ml) was calculated, which provides an optimal balance of sensitivity, specificity and accuracy of the prognostic model. These data support the potential value of sST2 as a biomarker of AHF in STEMI.
first_indexed 2024-04-09T20:44:06Z
format Article
id doaj.art-1167ecbccb104a8bb281a633c94132c5
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2024-04-09T20:44:06Z
publishDate 2021-05-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-1167ecbccb104a8bb281a633c94132c52023-03-29T21:23:38Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202021-05-0126410.15829/1560-4071-2021-43083213Role of soluble ST2 in short-term prediction of acute heart failure in acute ST-elevation myocardial infarctionO. S. Donirova0K. V. Protasov1B. A. Donirov2E. V. Batunova3N.A. Semashko Republican Clinical HospitalIrkutsk State Medical Academy of Postgraduate Education — Russian Medical Academy of Continuing Professional EducationN.A. Semashko Republican Clinical HospitalIrkutsk State Medical Academy of Postgraduate Education — Russian Medical Academy of Continuing Professional EducationAim. To investigate the relationship of soluble ST2 (sST2) to acute heart failure (AHF) and compare the predictive value of sST2 and brain natriuretic peptide in patients with ST-elevation myocardial infarction (STEMI).Material and methods. In 136 STEMI patients, the serum sST2 concentration was determined during the first 24 hours of hospitalization. We assessed levels of sST2, N-terminal pro-brain natriuretic peptide (NT-proBNP), incidence of Killip class II-IV AHF during hospitalization, myocardial necrosis biomarkers, parameters of complete blood count and biochemical blood tests, the incidence of cardiovascular diseases and risk factors. The predictive value of sST2 for AHF development was assessed using logistic regression. ROC analysis was performed. The areas under the ROC curve were compared for sST2 and NT-proBNP. The cut-off sST2 value was determined for predicting AHF.Results. The mean sST2 level was 43,4 (33,6-73,9) ng/ml. During the followup period, AHF was diagnosed in 54 people (39,7%). The prevalence of AHF in the 1st, 2nd and 3rd tertiles of sST2 was 15,6%, 33,3% and 69,7%, respectively. The NT-proBNP levels were 319 (128-1072) pg/ml, 430 (147-1140) pg/ml and 1317 (533-2386) pg/ml. The predictive value of 3rd sST2 tertile was retained adjusted for age, sex, NT-proBNP, troponin T, creatine phosphokinase-MB, high-sensitivity C-reactive protein, hemoglobin, blood glucose, left ventricular ejection fraction. The areas under the ROC curves for sST2 and NT-proBNP were comparable (0,828 and 0,733, respectively; p=0,056). The cut-off sST2 value was 64 ng/ml, above which the odds ratio of AHF was 11,1 (95% confidence interval, 4,7-26,1.Conclusion. An increase in blood sST2 is associated with an increase in AHF (Killip II-IV) prevalence in hospitalized patients with acute STEMI. Soluble ST2 has an independent predictive value for AHF in STEMI, comparable in strength and predictive model quality to NT-proBNP. The cut-off sST2 value for AHF (>64 ng/ ml) was calculated, which provides an optimal balance of sensitivity, specificity and accuracy of the prognostic model. These data support the potential value of sST2 as a biomarker of AHF in STEMI.https://russjcardiol.elpub.ru/jour/article/view/4308myocardial infarctionacute heart failuresoluble st2
spellingShingle O. S. Donirova
K. V. Protasov
B. A. Donirov
E. V. Batunova
Role of soluble ST2 in short-term prediction of acute heart failure in acute ST-elevation myocardial infarction
Российский кардиологический журнал
myocardial infarction
acute heart failure
soluble st2
title Role of soluble ST2 in short-term prediction of acute heart failure in acute ST-elevation myocardial infarction
title_full Role of soluble ST2 in short-term prediction of acute heart failure in acute ST-elevation myocardial infarction
title_fullStr Role of soluble ST2 in short-term prediction of acute heart failure in acute ST-elevation myocardial infarction
title_full_unstemmed Role of soluble ST2 in short-term prediction of acute heart failure in acute ST-elevation myocardial infarction
title_short Role of soluble ST2 in short-term prediction of acute heart failure in acute ST-elevation myocardial infarction
title_sort role of soluble st2 in short term prediction of acute heart failure in acute st elevation myocardial infarction
topic myocardial infarction
acute heart failure
soluble st2
url https://russjcardiol.elpub.ru/jour/article/view/4308
work_keys_str_mv AT osdonirova roleofsolublest2inshorttermpredictionofacuteheartfailureinacutestelevationmyocardialinfarction
AT kvprotasov roleofsolublest2inshorttermpredictionofacuteheartfailureinacutestelevationmyocardialinfarction
AT badonirov roleofsolublest2inshorttermpredictionofacuteheartfailureinacutestelevationmyocardialinfarction
AT evbatunova roleofsolublest2inshorttermpredictionofacuteheartfailureinacutestelevationmyocardialinfarction